Cencora, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cencora, Inc. on June 4, 2025. The filing details significant amendments to the Company's existing credit facilities and the termination of a prior short-term credit agreement. The Company operates as a pharmaceutical services provider with principal executive offices in Conshohocken, PA.
Key Financial Metrics and Debt Structure
The filing focuses on the restructuring of the Company's debt facilities rather than reporting operational financial metrics such as revenue or profit. Key debt terms established or modified include:
- Revolving Credit Facility: Increased aggregate commitments to $4.5 billion with a maturity date extended to June 4, 2030.
- Term Loan Facility: Amended to conform terms with the new Revolving Credit Facility.
- Interest Rates:
- Revolving: 69.5 to 110 basis points over Term SOFR/Adjusted Term CORRA/EURIBO/RFR; 0 to 10 basis points over alternate base rate.
- Term Loan: 87.5 to 137.5 basis points over adjusted Term SOFR; 0 to 37.5 basis points over alternate base rate.
- Facility Fees: Revolving facility fees range from 5.5 to 15 basis points annually on total commitments.
- Liquidity: Up to $100 million available for letters of credit under the Revolving Credit Facility.
Material Changes Versus Prior Period
The Company executed the following material changes to its financing arrangements:
- Expansion of Capacity: The Revolving Credit Facility was amended and restated to increase commitments to $4.5 billion, replacing the previous facility structure.
- Extension of Maturity: The maturity of the Revolving Credit Facility was extended to June 4, 2030.
- Termination of Prior Agreement: The $1.0 billion "364 Day Credit Agreement" (dated November 26, 2024, expiring January 1, 2026) was terminated.
- Covenant Adjustments: Both facilities now include a financial leverage ratio covenant not to exceed 4.00 to 1.00. This may be increased to 4.50 to 1.00 for up to three fiscal quarters following a "Material Acquisition" (cash consideration of at least $500 million).
Outlook, Risks, and Management Commentary
The Company intends to use funds from the Revolving Credit Facility for general corporate purposes. The interest rates and fees are variable, tied to the Company's public debt ratings from Standard & Poor's, Moody's, and Fitch. The agreements contain standard affirmative and negative covenants, including limitations on indebtedness, liens, fundamental changes, and asset sales. Events of default include non-payment, covenant breaches, and bankruptcy-related events. The filing notes that certain lenders and their affiliates have existing relationships with the Company, including investment banking and underwriting services.
Investor Verification Checklist
- Verify the current public debt ratings from S&P, Moody's, and Fitch to determine the applicable interest rate margins.
- Review the full text of the Amended and Restated Credit Agreement (Exhibit 10.1) for specific covenant definitions and exceptions.
- Confirm the Company's current leverage ratio to ensure compliance with the 4.00 to 1.00 threshold.
- Monitor for any announced "Material Acquisitions" that would trigger the temporary increase in the leverage ratio covenant to 4.50 to 1.00.
- Check the Company's outstanding letter of credit usage to assess remaining availability under the $4.5 billion facility.